Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Case report

Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: a case report

Authors: Erik Bathoorn, Natalia Escobar Salazar, Shahrzad Sepehrkhouy, Martin Meijer, Hans de Cock, Pieter-Jan Haas

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Aspergillus tubingensis is a black Aspergillus belonging to the Aspergillus section Nigri, which includes species that morphologically resemble Aspergillus niger. Recent developments in species determination have resulted in clinical isolates presumed to be Aspergillus niger being reclassified as Aspergillus tubingensis by sequencing. We present a report of a patient with an osteomyelitis of the maxillary bone with a probable invasive Aspergillus tubingensis infection.

Case presentation

We describe an immune compromised patient suffering from osteomyelitis of the maxillary bone after tooth extraction. The osteomyelitis probably resulted in dentogenic pansinusitis presenting as an acute ethmoiditis. Histologic examination of biopsy samples showed osteomyelitis, and inflammation of the surrounding connective tissue. Cultures of the alveolar wound grew Aspergillus tubingensis. The patient was treated with liposomal amphoterocin B, which was changed to oral treatment with voriconazole based on susceptibility testing (MIC for voriconazole was 1 μg/ml).

Conclusion

This case shows that Aspergillus tubingensis may have the potential to cause severe invasive infections in immunocompromised hosts. A larger proportion of Aspergillus tubingensis isolates are less susceptible to azoles compared to Aspergillus niger. Therefore, correct species identification and susceptibility testing is crucial for the choice of anti-fungal treatment, screening of azole resistance, and characterization of the pathogenic potential of the various species within Aspergillus section Nigri.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mosseray R: Les aspergillus de la section “Niger” Thom et Church. La Cellule Journal. 1934, 43: 203-285. Mosseray R: Les aspergillus de la section “Niger” Thom et Church. La Cellule Journal. 1934, 43: 203-285.
2.
go back to reference Perrone G, Varga J, Susca A, Frisvad JC, Stea G, Kocsube S, et al: Aspergillus uvarum sp. nov., an uniseriate black Aspergillus species isolated from grapes in Europe. Int J Syst Evol Microbiol. 2008, 58: 1032-1039. 10.1099/ijs.0.65463-0.CrossRefPubMed Perrone G, Varga J, Susca A, Frisvad JC, Stea G, Kocsube S, et al: Aspergillus uvarum sp. nov., an uniseriate black Aspergillus species isolated from grapes in Europe. Int J Syst Evol Microbiol. 2008, 58: 1032-1039. 10.1099/ijs.0.65463-0.CrossRefPubMed
3.
go back to reference Samson RA, Noonim P, Meijer M, Houbraken J, Frisvad JC, Varga J: Diagnostic tools to identify black aspergilli. Stud Mycol. 2007, 59: 129-145. 10.3114/sim.2007.59.13.CrossRefPubMedPubMedCentral Samson RA, Noonim P, Meijer M, Houbraken J, Frisvad JC, Varga J: Diagnostic tools to identify black aspergilli. Stud Mycol. 2007, 59: 129-145. 10.3114/sim.2007.59.13.CrossRefPubMedPubMedCentral
4.
go back to reference Perrone G, Stea G, Epifani F, Varga J, Frisvad JC, Samson RA: Aspergillus niger contains the cryptic phylogenetic species A. awamori. Fungal Biol. 2011, 115: 1138-1150. 10.1016/j.funbio.2011.07.008.CrossRefPubMed Perrone G, Stea G, Epifani F, Varga J, Frisvad JC, Samson RA: Aspergillus niger contains the cryptic phylogenetic species A. awamori. Fungal Biol. 2011, 115: 1138-1150. 10.1016/j.funbio.2011.07.008.CrossRefPubMed
5.
6.
go back to reference Meijer M, Houbraken JA, Dalhuijsen S, Samson RA, de Vries RP: Growth and hydrolase profiles can be used as characteristics to distinguish Aspergillus niger and other black aspergilli. Stud Mycol. 2011, 69: 19-30. 10.3114/sim.2011.69.02.CrossRefPubMedPubMedCentral Meijer M, Houbraken JA, Dalhuijsen S, Samson RA, de Vries RP: Growth and hydrolase profiles can be used as characteristics to distinguish Aspergillus niger and other black aspergilli. Stud Mycol. 2011, 69: 19-30. 10.3114/sim.2011.69.02.CrossRefPubMedPubMedCentral
7.
go back to reference Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing: EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect. 2008, 14: 982-984.CrossRef Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing: EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect. 2008, 14: 982-984.CrossRef
8.
go back to reference Munguia R, Daniel SJ: Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008, 72: 453-459. 10.1016/j.ijporl.2007.12.005.CrossRefPubMed Munguia R, Daniel SJ: Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008, 72: 453-459. 10.1016/j.ijporl.2007.12.005.CrossRefPubMed
9.
go back to reference Winslow CP, Dichard A, McGuire KA: Osteomyelitis of the temporomandibular joint. Am J Otolaryngol. 2001, 22: 142-145. 10.1053/ajot.2001.22577.CrossRefPubMed Winslow CP, Dichard A, McGuire KA: Osteomyelitis of the temporomandibular joint. Am J Otolaryngol. 2001, 22: 142-145. 10.1053/ajot.2001.22577.CrossRefPubMed
10.
go back to reference Abrahams JJ, Berger SB: Oral-maxillary sinus fistula (oroantral fistula): clinical features and findings on multiplanar CT. AJR Am J Roentgenol. 1995, 165: 1273-1276.CrossRefPubMed Abrahams JJ, Berger SB: Oral-maxillary sinus fistula (oroantral fistula): clinical features and findings on multiplanar CT. AJR Am J Roentgenol. 1995, 165: 1273-1276.CrossRefPubMed
11.
go back to reference Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al: Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012, 55: 333-338. 10.1111/j.1439-0507.2011.02103.x.CrossRefPubMed Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al: Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012, 55: 333-338. 10.1111/j.1439-0507.2011.02103.x.CrossRefPubMed
12.
go back to reference Arabatzis M, Kambouris M, Kyprianou M, Chrysaki A, Foustoukou M, Kanellopoulou M, et al: Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece. Antimicrob Agents Chemother. 2011, 55: 3025-3030. 10.1128/AAC.01491-10.CrossRefPubMedPubMedCentral Arabatzis M, Kambouris M, Kyprianou M, Chrysaki A, Foustoukou M, Kanellopoulou M, et al: Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece. Antimicrob Agents Chemother. 2011, 55: 3025-3030. 10.1128/AAC.01491-10.CrossRefPubMedPubMedCentral
13.
go back to reference Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J: Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012, 174 (2): 143-147. 10.1007/s11046-012-9529-8.CrossRefPubMed Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J: Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012, 174 (2): 143-147. 10.1007/s11046-012-9529-8.CrossRefPubMed
14.
go back to reference Hendrickx M, Beguin H, Detandt M: Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection. Mycoses. 2012, 55: 148-155.PubMed Hendrickx M, Beguin H, Detandt M: Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection. Mycoses. 2012, 55: 148-155.PubMed
15.
go back to reference Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, et al: Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J Clin Microbiol. 2009, 47: 3138-3141. 10.1128/JCM.01070-09.CrossRefPubMedPubMedCentral Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, et al: Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J Clin Microbiol. 2009, 47: 3138-3141. 10.1128/JCM.01070-09.CrossRefPubMedPubMedCentral
16.
go back to reference Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL: Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother. 2009, 53: 4514-4517. 10.1128/AAC.00585-09.CrossRefPubMedPubMedCentral Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL: Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother. 2009, 53: 4514-4517. 10.1128/AAC.00585-09.CrossRefPubMedPubMedCentral
17.
go back to reference Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW: Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011, 55: 4802-4809. 10.1128/AAC.00304-11.CrossRefPubMedPubMedCentral Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW: Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011, 55: 4802-4809. 10.1128/AAC.00304-11.CrossRefPubMedPubMedCentral
18.
go back to reference Meletiadis J, Mavridou E, Melchers WJ, Mouton JW, Verweij PE: Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob Agents Chemother. 2012, 56 (5): 2524-2529. 10.1128/AAC.05959-11.CrossRefPubMedPubMedCentral Meletiadis J, Mavridou E, Melchers WJ, Mouton JW, Verweij PE: Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob Agents Chemother. 2012, 56 (5): 2524-2529. 10.1128/AAC.05959-11.CrossRefPubMedPubMedCentral
Metadata
Title
Involvement of the opportunistic pathogen Aspergillus tubingensis in osteomyelitis of the maxillary bone: a case report
Authors
Erik Bathoorn
Natalia Escobar Salazar
Shahrzad Sepehrkhouy
Martin Meijer
Hans de Cock
Pieter-Jan Haas
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-59

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.